Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Réjean Lapointe

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cancer Research|February 21, 2006
Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartmentsStéphanie Lepage, Réjean Lapointe
APL Bioengineering|December 23, 2022
Biomaterials for enhanced immunotherapyNicholas Cunningham, Réjean Lapointe, Sophie Lerouge
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2022
Blood Sample Processing and Banking for Functional and Molecular AnalysesPaméla Thébault, Jean-François Cailhier, Réjean Lapointe
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
mRNA PCR-based epitope chase methodJean-Daniel Doucet, Dominique Gauchat, Réjean Lapointe
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Identification of T-cell epitopes by a novel mRNA PCR-based epitope chase techniqueJean-Daniel Doucet, Dominique Gauchat, Réjean Lapointe
Oncoimmunology|November 20, 2012
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapyJacques Thibodeau, Marie-Claude Bourgeois-Daigneault, Réjean Lapointe
European Journal of Immunology|March 20, 2014
The WT hemochromatosis protein HFE inhibits CD8⁺ T-lymphocyte activationAlexandre Reuben, Mikaël Phénix, Manuela M Santos, et al.
Biomaterials|October 30, 2015
Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapiesAnne Monette, Caroline Ceccaldi, Elias Assaad, et al.
Cytokine|April 17, 2012
MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expressionTristan Galbas, Viktor Steimle, Réjean Lapointe, et al.
Immunity, Inflammation and Disease|May 6, 2017
The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune systemAlexandre Reuben, Jacqueline W Chung, Réjean Lapointe, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cancer Research|February 21, 2006
Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartmentsStéphanie Lepage, Réjean Lapointe
APL Bioengineering|December 23, 2022
Biomaterials for enhanced immunotherapyNicholas Cunningham, Réjean Lapointe, Sophie Lerouge
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2022
Blood Sample Processing and Banking for Functional and Molecular AnalysesPaméla Thébault, Jean-François Cailhier, Réjean Lapointe
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
mRNA PCR-based epitope chase methodJean-Daniel Doucet, Dominique Gauchat, Réjean Lapointe
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Identification of T-cell epitopes by a novel mRNA PCR-based epitope chase techniqueJean-Daniel Doucet, Dominique Gauchat, Réjean Lapointe
Oncoimmunology|November 20, 2012
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapyJacques Thibodeau, Marie-Claude Bourgeois-Daigneault, Réjean Lapointe
European Journal of Immunology|March 20, 2014
The WT hemochromatosis protein HFE inhibits CD8⁺ T-lymphocyte activationAlexandre Reuben, Mikaël Phénix, Manuela M Santos, et al.
Biomaterials|October 30, 2015
Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapiesAnne Monette, Caroline Ceccaldi, Elias Assaad, et al.
Cytokine|April 17, 2012
MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expressionTristan Galbas, Viktor Steimle, Réjean Lapointe, et al.
Immunity, Inflammation and Disease|May 6, 2017
The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune systemAlexandre Reuben, Jacqueline W Chung, Réjean Lapointe, et al.
Pageof 6